RT Journal Article
T1 Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology.
T2 Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología.
A1 Palacio-Portilla, E J
A1 Roquer, J
A1 Amaro, S
A1 Arenillas, J F
A1 Ayo-Martín, O
A1 Castellanos, M
A1 Freijo, M M
A1 Fuentes, B
A1 García-Pastor, A
A1 Gomis, M
A1 Gómez-Choco, M
A1 López-Cancio, E
A1 Martínez-Sánchez, P
A1 Morales, A
A1 Rodríguez-Yáñez, M
A1 Segura, T
A1 Serena, J
A1 Vivancos-Mora, J
A1 de Leciñana, M A
A1 Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología, 
K1 Dislipidemia
K1 Dyslipidaemia
K1 Estatinas
K1 Ictus
K1 LDL cholesterol
K1 LDL colesterol
K1 Prevención
K1 Prevention
K1 Statins
K1 Stroke
AB We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia. We performed a systematic review to evaluate the main aspects of the management of dyslipidaemias in primary and secondary stroke prevention and establish a series of recommendations. In primary prevention, the patient's vascular risk should be determined in order to define target values for low-density lipoprotein cholesterol. In secondary prevention after an atherothrombotic stroke, a target value
YR 2020
FD 2020-11-04
LK http://hdl.handle.net/10668/22444
UL http://hdl.handle.net/10668/22444
LA en
LA es
DS RISalud
RD Apr 8, 2025